Starx Research Center, LLC Report issue

For profit Phase 4
Founded: Edison NJ United States (2013)
Status: Defunct (2018)

Organization Overview

First Clinical Trial
2013
NCT01808768
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

alcaftadine (Lastacaft) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Conjunctivitis (Phase 4)

Conjunctivitis, Allergic (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1